Brokers usually take bids until: Zerodha 4:45 PM, Groww 4:50 PM, Angel One and Upstox 5:00 PM (HNI 4:00 PM). Check the exact time with your broker or bank.
Total Issue Size
Fresh Issue + Offer For Sale
Fresh Issue (FI)
Proceeds go to the company
Offer For Sale (OFS)
Proceeds go to the existing investors
Repayment of borrowings
Funds will be used to repay or prepay, in full or in part, certain outstanding borrowings availed by the company and its material subsidiary.
General corporate purposes
The remaining net proceeds will be used for general corporate purposes as permitted under applicable regulations.
(₹ in Crore)
Tap a bar to highlight a metric across periods and show its values.
Jupiter Life Line Hospitals Limited is a multi-specialty tertiary and quaternary care hospital operator focused on complex medical treatment across specialties such as cardiac care, oncology, neurosciences, orthopaedics, and organ transplants. The company runs its hospitals under the Jupiter brand and follows a hub model in which each facility offers a broad range of specialties under one roof rather than relying on smaller satellite centres. Incorporated in 2007, the company operates three hospitals located in Thane, Pune, and Indore, together housing close to 1,200 operational beds and supported by more than 1,300 doctors, including specialists, physicians, and surgeons, as of the end of FY23. Its flagship Thane facility anchors group operations and contributes a large share of overall revenue. The promoters, Dr. Ajay Thakker and Dr. Ankit Thakker, along with Western Medical Solutions LLP, have built the group's clinical reputation over more than a decade and a half in the Mumbai Metropolitan Region and the wider western India healthcare market. The company recorded strong topline and profitability growth in the years leading up to its public listing, moving from a net loss in FY21 to a net profit of roughly Rs 73 crore in FY23 on the back of rising occupancy, a richer case mix, and operating leverage. Its growth strategy centres on deepening its presence in existing markets, adding capacity at current hospitals, and selectively expanding into new geographies within western India.
The company raised approximately Rs 260.72 crore from 39 anchor investors at the upper price band of Rs 735 per share, with participation from marquee domestic and international institutions including SBI Mutual Fund, ICICI Prudential, HDFC Mutual Fund, Axis Mutual Fund, the Government of Singapore, the Abu Dhabi Investment Authority, Goldman Sachs, and Fidelity Funds.
Source: RHP • Analysis provided for informational purposes
Last Updated: 18 July 2026, 5:30 AM
Established multi-specialty hospital brand
The Jupiter brand has built over 15 years of clinical reputation and patient trust in tertiary and quaternary care across cardiac, oncology, neuroscience, and other specialties.
Hub-based, full-service hospital model
Rather than running a network of smaller satellite centres, the company operates full-service hospitals under one roof, supporting complex, high-acuity procedures with integrated infrastructure.
Ability to attract and retain clinical talent
The company has built a large base of specialists, physicians, and surgeons, which supports its ability to handle complex cases and sustain quality of care.
Strong and improving financial performance
Revenue grew at a compound rate of roughly 35% between FY21 and FY23, with the company turning a FY21 net loss into a net profit of about Rs 73 crore in FY23, alongside a meaningfully higher EBITDA margin.
Concentration in one flagship hospital and one region
A large share of revenue comes from the Thane hospital, and all facilities are located in western India, leaving the business exposed to any regional economic slowdown or disruption.
Exposure to healthcare regulation
Hospital operations are subject to extensive regulatory oversight, and adverse changes in healthcare, environmental, or labour regulations could increase compliance costs or restrict operations.
Ongoing legal proceedings
The company is party to a few pending legal matters, including a dispute over land use in connection with a hotel located on the Thane hospital premises, an adverse outcome in which could affect its reputation or operations.
Jupiter Life Line Hospitals Limited
1004, 10th Floor, 360 Degree Business Park, Maharana Pratap Chowk, LBS Marg, Mulund (West), Mumbai - 400080, Maharashtra, India
View on Maps →No financial information whatsoever published anywhere, within this website, should be considered as an advice to buy or sell securities or invest in IPOs, or as a guide to doing so in any way whatsoever. All matter published here is purely for educational and information purposes only and under no circumstances should be used for making investment decisions.
We are not a SEBI Registered analyst. Readers must consult a qualified financial advisor prior to making any actual investment decisions, based on information published on this website. The information on this website is based on information available as on date coupled with market perceptions.
You agree with the terms and conditions to use this website.
Grey-market disclaimer. GMP shown here is grey-market news only. We do not trade or deal in the grey market or subject-to rates, nor do we recommend trading in the grey market.
Not investment advice. IPO Nex is an information tool, not investment advice. We do not recommend buying or selling any securities. Always do your own research before applying to any IPO.
IPO Nex does not guarantee any listing gain or return. IPO investments are subject to market risks.
All times are IST.
© 2026 IPO Nex by Niota. All rights reserved.